ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Treating Asthma with Stem Cells – Technology Networks

Continue reading

2017-06-30 Michael Zand NEWS

7th International Conference and Exhibition on Cell and Gene Therapy – Technology Networks

Technology Networks7th International Conference and Exhibition on Cell and Gene TherapyTechnology NetworksConference Series LLC welcomes you to attend the 7th International Conference and Exhibition on Cell & Gene Therapy during March 15-17, 2018 a… Continue reading

2017-06-30 Michael Zand NEWS

Lonza expands in Asia: 8000L single-use in Singapore, regenerative meds in Japan – BioPharma-Reporter.com


Technology Networks

Treating Asthma with Stem Cells
Technology Networks
The Monash Biomedicine Discovery Institute (BDI) scientists provided the experimental expertise to test Cynata Therapeutics’ induced pluripotent stem cell-derived mesenchymal stem cells (MSCs) in a model of experimental asthma. Induced pluripotent stem …

and more »

Continue reading

2017-06-30 Michael Zand NEWS

eTheRNA Immunotherapies Advances In-Vivo mRNA Cancer Immunotherapy into First Oncology Clinical Studies – PR Newswire (press release)


BioPharma-Reporter.com

Lonza expands in Asia: 8000L single-use in Singapore, regenerative meds in Japan
BioPharma-Reporter.com
The firm recently acquired European cell and gene therapy maker PharmaCell in a deal that a spokesperson told this publication places Lonza as the “leading contract development and manufacturing organisation offering an international cell and gene …

Continue reading

2017-06-30 Michael Zand NEWS

SB 7.0 Conference: Global Strides in Synthetic Biology – Biotechin.Asia

eTheRNA Immunotherapies Advances In-Vivo mRNA Cancer Immunotherapy into First Oncology Clinical Studies
PR Newswire (press release)
TriMix-MEL is a rationally designed, investigational immunotherapy comprising eTheRNA’s core TriMix mRNAs, which include a unique combination of three mRNAs encoding proteins that act highly synergistically via three different pathways for the optimal …

Continue reading

2017-06-30 Michael Zand NEWS

SB 7.0 Conference: Global Strides in Synthetic Biology – Biotechin.Asia


Biotechin.Asia

SB 7.0 Conference: Global Strides in Synthetic Biology
Biotechin.Asia
The Seventh International Meeting on Synthetic Biology held from 13 – 16th of June at the National University of Singapore concluded recently. Its objective was to unite the different international synthetic biology communities to come together to …

Continue reading

2017-06-30 Michael Zand NEWS

Stem cell therapy gives hope to patients with chronic illness – WDAM-TV


Biotechin.Asia

SB 7.0 Conference: Global Strides in Synthetic Biology
Biotechin.Asia
The Seventh International Meeting on Synthetic Biology held from 13 – 16th of June at the National University of Singapore concluded recently. Its objective was to unite the different international synthetic biology communities to come together to …

Continue reading

2017-06-30 Michael Zand NEWS

$5 billion stem cell bond scrapped for 2018 ballot – Capitol Weekly

Capitol Weekly$5 billion stem cell bond scrapped for 2018 ballotCapitol WeeklyPlans to ask California voters in 2018 to approve a $5 billion bond issue to finance the California stem cell agency have been shelved, a director of the agency said Thursday… Continue reading

2017-06-29 Michael Zand NEWS
  • 1
  • …
  • 1,558
  • 1,559
  • 1,560
  • 1,561
  • 1,562
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Stem cell therapy gives hope to patients with chronic illness
WDAM-TV
HATTIESBURG, MS (WDAM) -. A new, innovative stem cell therapy happening in a Hattiesburg clinic is giving hope to patients with chronic inflammatory conditions. Todd Louviere has had Multiple Sclerosis for more than 20 years. “When it was at it’s worst …